Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction.

The Journal of Clinical Investigation
M J StoneM R Waterman

Abstract

A radioimmunoassay has been developed for the measurement of serum myoglobin in order to evaluate the time-course and frequency of myoglobinemia in patients with acute myocardial infarction. The method can detect as little as 0.5 ng of myoglobin and is not affected by hemolysis or storage of serum at -- 20 degrees C. Myoglobin was detected in all of 92 sera from normal adults and ranged between 6 and 85 ng/ml. Levels were markedly elevated in sera from 18 of 20 patients with acute myocardial infarction when samples were obtained within 12 h after hospital admission, the mean concentration being 380+/-53 ng/ml. Wehn the initial sample was drawn between 12 and 24 h after admission in another group of 20 patients with acute myocardial infarcts, the mean serum myoglobin concentration was 195+/-47 ng/ml, and 11 of these individuals had normal levels. Serial determinations performed on nine patients with acute infarction demonstrated that maximum myoglobin levels occurred within the first 8-12 h after admission and fell rapidly toward normal thereafter. The serum concentration of myoglobin in 21 additional patients admitted with chest pain but without acute myocardial infarction was 41+/-6 ng/ml. Radioimmunoassay of serum myoglobin a...Continue Reading

References

Feb 1, 1975·The American Journal of Medicine·L KagenH Paul
Nov 1, 1973·Annals of Internal Medicine·R Roberts, B E Sobel

❮ Previous
Next ❯

Citations

Nov 1, 1977·Arthritis and Rheumatism·M Nishikai, M Reichlin
Jan 1, 1990·Journal of Clinical Laboratory Analysis·H MoscosoF A Garver
Jan 1, 1991·Journal of Clinical Laboratory Analysis·L BorqueR Ruiz
Jan 1, 1981·Journal of Neurology·W R KiesslingI Haubitz
Jun 1, 1989·European Journal of Pediatrics·J A SmeitinkM J Kock-Jansen
Jan 1, 1983·Histochemistry·E Jansson, C Sylvén
Mar 1, 1986·Canadian Anaesthetists' Society Journal·V F BlancG Brisson
Aug 27, 2013·European Journal of Applied Physiology·Brian R KupchakJeff S Volek
Apr 1, 1983·American Heart Journal·H DrexelF Dienstl
Apr 3, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·T AndoY Fukuyama
Sep 8, 1980·Clinica Chimica Acta; International Journal of Clinical Chemistry·A MaddisonP Sleight
Oct 23, 1980·Clinica Chimica Acta; International Journal of Clinical Chemistry·L E RoxinL Wide
Sep 15, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·M A GrachevV V Roschke
Mar 27, 1984·Clinica Chimica Acta; International Journal of Clinical Chemistry·T OlssonA Thore
Jan 30, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·J P Chapelle, C Heusghem
Sep 30, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·P P SimeonovaS D Kyurkchiev
Oct 1, 1994·Clinical Biochemistry·J P ChapelleL Piérard
Feb 1, 1995·Clinical Biochemistry·V Bhayana, A R Henderson
Sep 1, 1981·Journal of the Neurological Sciences·L V Nicholson
Sep 1, 1982·Journal of the Neurological Sciences·M KonagayaI Sobue
Jan 1, 1978·Immunochemistry·A L Kazim, M Z Atassi
Feb 18, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mauro PanteghiniHeinz Schimmel
May 12, 2000·The American Journal of Medicine·H M TrimarchiE A Freixas
Jul 20, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·V A NikulinaA D Dmitriev
Jul 10, 1998·Clinica Chimica Acta; International Journal of Clinical Chemistry·H QiaojiaZ Zhongyong
May 5, 1977·The New England Journal of Medicine·L D Hillis, E Braunwald
Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J T WillersonL B Hersh
Jan 1, 1980·Journal of Immunoassay·A C VanderbrouckeJ Gauldie
Feb 1, 1983·Acta Physiologica Scandinavica·J SvedenhagC Sylvén
Oct 1, 1985·Archives of Disease in Childhood·T KojimaY Kobayashi
Feb 1, 1987·Annals of the Rheumatic Diseases·J C BorleffsD P Bär
Jan 1, 1977·British Heart Journal·T G DonaldD E Wilcken
Apr 1, 1977·British Heart Journal·M J StoneJ T Willerson
Apr 1, 1982·British Heart Journal·J M McComb, E A McMaster
Feb 1, 1984·British Heart Journal·J M McCombA A Adgey
Jan 1, 1981·Journal of Neurology, Neurosurgery, and Psychiatry·H AskmarkP Venge
Feb 18, 2005·American Journal of Clinical Pathology·Zehava Chen-LevyJames S Fine
Jul 25, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·I PenttiläT Rantanen
Jan 1, 1994·Intensive Care Medicine·Y WakabayashiR Kikawada
Jun 1, 1983·Kidney International·N Honda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.